Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing
Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing
复制标题
DOI：
10.1016/j.mayocp.2017.11.001
复制
发表时间：
2018-01-01
影响因子：
8.9
通讯作者：
Sharp, Richard R.
中科院分区：
文献类型：
--
作者：
Allyse, Megan A.;Robinson, David H.;Sharp, Richard R.
直接面向消费者（DTC）的基因检测出现在21世纪初，作为一种允许消费者在没有医生参与的情况下获得其遗传信息的手段。虽然DTC的早期模型受到消费者的欢迎，但它们在医疗和监管界存在争议。在这篇文章中，我们追溯了DTC基因检测的历史，讨论了其监管意义，并描述了一种新的混合模型的出现，我们称之为DTC 2.0。(C)2017年马约医学教育和研究基金会
Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0. (C) 2017 Mayo Foundation for Medical Education and Research